The pathophysiology of extrapyramidal side-effects of neuroleptic drugs

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Psychological Medicine

• Publication date

  1980-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S003329170003960XPMID 6104342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine

  2005cited by this paper
• Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in Vivo using an inhibitor of the aromatic amino acid decarboxylase

  2004cited by this paper
• ReviewCatecholamines: Basic and clinical frontiers: Usdin, E., Kopin, I. J. and Barchas, J. (Eds.) (1979) 2 volumes, 1953 pp. Oxford: Pergamon Press

  1981cited by this paper
• EFFECTS OF CHRONIC HALOPERIDOL TREATMENT ON SPONTANEOUS ACTIVITY IN THE CAUDATE NUCLEUS

  1979cited by this paper
• Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Changes in dopamine-mediated behaviour during one year's neuroleptic administration.

  1979cited by this paper
• Localization of dopamine receptors in rat brain.

  1979cited by this paper
• Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals.

  1978cited by this paper
• An experimental model of tardive dyskinesias.

  1978cited by this paper
• Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment

  1978cited by this paper
• Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones.

  1978cited by this paper
• Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors.

  1978cited by this paper
• The tardive dyskinesia syndrome.

  1978cited by this paper
• Studies on the role of catecholamines in the frontal cortex [proceedings].

  1978cited by this paper
• Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.

  1978cited by this paper
• Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat.

  1978cited by this paper
• The tardive dyskinesia syndrome.

  1978cited by this paper
• Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration.

  1977cited by this paper
• Haloperidol-Induced Dyskinesias in the Monkey

  1977cited by this paper
• Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.

  1977cited by this paper
• Dopamine “Autoreceptors”: Pharmacological characterization by microiontophoretic single cell recording studies

  1977cited by this paper
• Release of dopamine in vivo from cat substantia nigra

  1977cited by this paper
• Postsynaptic receptors are not essential for dopaminergic feedback regulation

  1977cited by this paper
• Feedback loop or output pathway in striato-nigral fibres?

  1977cited by this paper
• Contractual agreements with adolescents?

  1977cited by this paper
• Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.

  1977cited by this paper
• Acute dystonia as an idiosyncratic response to neuroleptics in baboons.

  1977cited by this paper
• Relationship between tardive dyskinesia, l-Dopa-induced hyperkinesia and parkinsonism

  1977cited by this paper
• Does dopamine play a role in schizophrenia?

  1977cited by this paper
• Effects of dopamine agonists in tardive dyskinesia.

  1977cited by this paper
• Movement disorders induced in monkeys by chronic haloperidol treatment

  1977cited by this paper
• Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.

  1977cited by this paper
• Paradoxical response to dopamine agonists in tardive dyskinesia.

  1977cited by this paper
• The relationship between parkinsonism and tardive dyskinesia.

  1977cited by this paper
• Antipsychotic Drugs: Clinical Pharmacology and Therapeutic Use

  1977cited by this paper
• Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

  1977cited by this paper
• Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices.

  1977cited by this paper
• Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum.

  1977cited by this paper
• Epidemiology of tardive dyskinesia Part I.

  1976cited by this paper
• Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

  1976cited by this paper
• Single and repeated administration of neuroleptic drugs to rats: Effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-dopa

  1976cited by this paper
• The primary hereditary dystonias: genetic classification of 768 families and revised estimate of gene frequency, autosomal recessive form, and selected bibliography.

  1976cited by this paper
• Haloperidol-induced tardive dyskinesia in monkeys

  1976cited by this paper
• Dopamine-sensitive adenylate cyclase in homogenates of rat striata during ethanol and barbiturate withdrawal

  1976cited by this paper
• Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.

  1976cited by this paper
• Pharmacokinetics of red blood cell phenothiazine and clinical effects. Acute dystonic reactions.

  1976cited by this paper
• Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes.

  1976cited by this paper
• Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum.

  1976cited by this paper
• Evidence for dopamine receptors mediating sedation in the mouse brain

  1976cited by this paper
• Letter: Chorea and torsion in parkinsonism.

  1976cited by this paper
• Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus.

  1976cited by this paper
• On the supersensitivity of dopamine receptors, induced by neuroleptics

  1976cited by this paper
• Dopamine receptors: selective agonists and antagonists of functionally distinct types within the feline brain.

  1976cited by this paper
• d-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway.

  1976cited by this paper
• Amphetamine-induced release of dopamine from the substantia nigra in vitro.

  1976cited by this paper
• CHOREA AND TORSION IN PARKINSONISM

  1976cited by this paper
• Epidemiology of tardive dyskinesia. Part II.

  1976cited by this paper
• Release of dopamine from dendrites in rat substantia nigra

  1976cited by this paper
• Dystonic reactions following neuroleptics: Time Course and proposed mechanisms

  1976cited by this paper
• Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.

  1975cited by this paper
• Self-inhibition by dopaminergic neurons

  1975cited by this paper
• Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.

  1975cited by this paper
• Inhibition by dopamine agonists of dopamine accumulation following γ-hydroxybutyrate treatment

  1975cited by this paper
• Inhibition by dopamine agonists of dopamine accumulation following gamma-hydroxybutyrate treatment.

  1975cited by this paper
• Neuroleptic antagonism of dyskinetic phenomena.

  1975cited by this paper
• Dopamine neurons: role of impulse flow and presynaptic receptors in the regulation of tyrosine hydroxylase.

  1975cited by this paper
• Parkinsonism induced by dopaminergic antagonists.

  1975cited by this paper
• Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

  1975cited by this paper
• Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.

  1975cited by this paper
• Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats.

  1975cited by this paper
• Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

  1974cited by this paper
• Effect of cholinergic and anticholinergic agents on tardive dyskinesia 1

  1974cited by this paper
• Bromocriptine in Parkinsonism

  1974cited by this paper
• Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients.

  1974cited by this paper
• On the coexistence of parkinsonism and tardive dyskinesia.

  1974cited by this paper
• Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates.

  1974cited by this paper
• Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice

  1974cited by this paper
• The dopamine-releasing actions of neuroleptics and ethanol.

  1974cited by this paper
• Mesencephalic dopamine neurons projecting to neocortex.

  1974cited by this paper
• Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

  1974cited by this paper
• Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways.

  1974cited by this paper
• Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

  1974cited by this paper
• On the coexistence of parkinsonism and tardive dyskinesia.

  1974cited by this paper
• Pharmaco-histochemical evidence of the existence of dopamine nerve terminals in the limbic cortex.

  1974cited by this paper
• Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.

  1973cited by this paper
• Pharmacologically induced behavioural supersensitivity to apomorphine.

  1973cited by this paper
• Persistent Dyskinesia

  1973cited by this paper
• Outpatient Maintenance of Chronic Schizophrenic Patients with Long-acting Fluphenazine: Double-blind Placebo

  1973cited by this paper
• Dopaminergic Terminals in the Rat Cortex

  1973cited by this paper
• Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.

  1973cited by this paper
• The pharmacology of tardive dyskinesias.

  1973cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti‐acetylcholine drugs

  1972cited by this paper
• Physiologic and clinical effects of chlorpromazine and their relationship to plasma level

  1972cited by this paper
• The pharmacology of extrapyramidal movement disorders.

  1972cited by this paper
• Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.

  1972cited by this paper
• Drug-induced extrapyramidal disorders.

  1972cited by this paper
• Regulation of monoamine metabolism in the central nervous system.

  1972cited by this paper

• Low-dose metoclopramide-induced dystonia in cannabis withdrawal syndrome manifesting as intractable nausea and vomiting

  2025cites this paper
• Spasmodic Dysphonia

  2025cites this paper
• IUPHAR REVIEW: Moving beyond dopamine-based therapeutic strategies for schizophrenia.

  2025cites this paper
• Electroconvulsive Therapy and Akathisia

  2024cites this paper
• Molecular and Behavioral Neuroprotective Effects of Clavulanic Acid and Crocin in Haloperidol-Induced Tardive Dyskinesia in Rats

  2024cites this paper
• Comparative Study of Extrapyramidal Side Effects, Sexual Dysfunctions and Hyperprolactinaemia Using Typical and Atypical Antipsychotic Medications Among Patients with Schizophrenia in Maiduguri

  2023cites this paper
• Appearance of extrapyramidal symptoms in adolescent psychiatry patients during COVID‐19 infection

  2023cites this paper
• Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic

  2022cites this paper
• Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review

  2021influential citation
• Agitation in the Emergency Department

  2021cites this paper
• Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.

  2021cites this paper
• Holistic approach to undifferentiated acute severe behavioural disturbance in older emergency department patients

  2021cites this paper
• Medikamenteninduzierte Dyskinesien

  2020cites this paper
• Paliperidone-Associated Acute Oculogyric Crisis.

  2020cites this paper
• NEUROPROTECTIVE EFFECT OF METHANOLIC EXTRACT OF SARGASSUM WIGHTII ON HALOPERIDOL INDUCED CATALEPSY AND TARDIVE DYSKINESIA IN ALBINO RATS

  2020cites this paper
• Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges

  2020cites this paper
• Treatment of Acute Dystonic Reactions

  2019cites this paper
• Évolution de la symptomatologie négative chez les patients schizophrènes hospitalisés

  2019cites this paper
• Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency

  2019cites this paper
• Tardive Syndromes.

  2019cites this paper
• Severe parkinsonism under treatment with antipsychotic drugs

  2019cites this paper
• Altered Mental Status in the Emergency Department

  2019cites this paper
• Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study

  2018cites this paper
• VMAT2 inhibitors for the treatment of tardive dyskinesia.

  2018cites this paper
• Pediatric Iatrogenic Movement Disorders.

  2018cites this paper
• Oculogyric crises: Etiology, pathophysiology and therapeutic approaches.

  2017cites this paper
• Beyond anxiety and agitation: A clinical approach to akathisia.

  2017cites this paper
• Subcortical dementia

  2017cites this paper
• Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction

  2017cites this paper
• Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study

  2017cites this paper
• Hyperkinetic Movement Disorder Emergencies

  2017cites this paper
• Artesunate/Amodiaquine-Induced Acute Extrapyramidal Reactions in Children and Younger Adults: Case Series Assessment

  2016cites this paper
• [Antipsychotic-induced tardive syndromes].

  2016cites this paper
• Antipsychotikainduzierte tardive Syndrome

  2016cites this paper
• Serotonergic perturbations in dystonia disorders-a systematic review.

  2016cites this paper
• EVALUATION O F ANTI-PARKINSONS ACTIVITY OF CARICA PAPAYA USING ALBINO RATS

  2016cites this paper
• Investigation of genetic loci associated with parkinson's disease and the functional effect of LRRK2 mutations / Aroma Agape Gopalai

  2016cites this paper
• Genetics of Common Antipsychotic-Induced Adverse Effects

  2016cites this paper
• Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence

  2015cites this paper
• The clinical challenges of akathisia

  2015cites this paper
• Consideraciones anestésicas para el manejo de fármacos en el paciente senil durante el período perioperatorio

  2015cites this paper
• Dopamine Receptors and Monoamine Oxidase as Virion Receptors

  2015cites this paper
• Higher fundamental voice frequency is related to extrapyramidal symptoms in schizophrenia.

  2015cites this paper
• Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration

  2015cites this paper
• Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice.

  2015cites this paper
• Medication-Induced Movement Disorders: Acute dystonia

  2015cites this paper
• Temporomandibular joint dislocation due to atypical antipsychotic-induced acute dystonia: a case report

  2014cites this paper
• A late appearance by the dopamine D‐3 receptor

  2014cites this paper
• Quetiapine in postpartum psychosis.

  2014cites this paper
• Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model.

  2014cites this paper
• Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

  2014cites this paper
• Glutamatergic dysfunction in skin-picking disorder: treatment of a pediatric patient with N-acetylcysteine.

  2014cites this paper
• A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs by D. G. Cunningham Owens

  2014cites this paper
• Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology

  2014cites this paper
• Atomoxetine-associated akathisia: a case report.

  2014cites this paper
• Behavioral Emergencies for the Emergency Physician: List of contributors

  2013cites this paper
• Movement Disorder Emergencies of the Upper Aerodigestive Tract

  2013cites this paper
• Treatment of neurolept-induced tardive dyskinesia

  2013cites this paper
• Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice

  2013cites this paper
• Cocaine-Induced Dystonic Reaction: An Unlikely Presentation of Child Neglect

  2013cites this paper
• A genetic dissection of antipsychotic induced movement disorders.

  2013cites this paper
• Phenothiazine‐Based Dopamine D2 Antagonists for the Treatment of Schizophrenia

  2013cites this paper
• Chloroquine-induced Acute Dystonic Reactions after a Standard Therapeutic Dose for Uncomplicated Malaria.

  2013cites this paper
• Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis

  2012cites this paper
• Evaluation of economic savings in drug therapy by dose adjustment to polymorphisms in cytochrome P450

  2012cites this paper
• Dystonia - The Many Facets

  2012cites this paper
• Chapter 14 – Nervous System and Special Sense Organs

  2012cites this paper
• Acute laryngeal dystonia associated with aripiprazole.

  2012cites this paper
• Breaking away from dopamine deficiency: an essential new direction for Parkinson’s disease

  2012cites this paper
• AN ACUTE DYSTONIA CASE INDUCED BY ADDITION OF QUETIAPINE WITH A SINGLE DOSE ON FLUOXETINE AND TRAZODONE

  2012cites this paper
• Dystonia Pathophysiology: A Critical Review

  2012cites this paper
• Tardive Dystonia with Olanzapine: A Rare Case Report

  2012cites this paper
• Bewertung der Einsparpotenziale in der Arzneimitteltherapie durch Dosisanpassung an die Polymorphismen im Cytochrom P450

  2012cites this paper
• A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia

  2012cites this paper
• Rate of Major Depressive Disorder and Life Quality of Migrainous Patients Treated with Propranolol or Flunarizine

  2012cites this paper
• Motor Symptoms and Schizophrenia

  2012cites this paper
• Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009).

  2012cites this paper
• The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.

  2011cites this paper
• Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients

  2011cites this paper
• Akathisia: An unusual movement disorder in Machado-Joseph disease.

  2011cites this paper
• The tardive syndromes

  2011cites this paper
• Experimental models of dystonia.

  2011cites this paper
• Nonprimary dystonias.

  2011cites this paper
• Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers

  2011cites this paper
• Effective blood transfusion for the symptomatic restless legs syndrome by anemia in the terminal stage of cancer: a case report

  2011cites this paper
• Neuromuscular complication after liver transplant in children: a single-center experience.

  2010cites this paper
• Antipsychotic drug side effects for persons with intellectual disability.

  2010cites this paper
• Abstracts of the 2010 Meeting of the International Neuro-Ophthalmology Society, Lyon, France

  2010cites this paper
• Akathisia: an updated review focusing on second-generation antipsychotics.

  2009cites this paper
• Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.

  2009cites this paper
• Primate models of dystonia.

  2009cites this paper
• [Akathisia--diagnosis, pathophysiology and therapy].

  2009cites this paper
• High-dose ziprasidone monotherapy in bipolar I disorder patients with depressed or mixed episodes.

  2008cites this paper
• Neuropsychiatric complications of commonly used palliative care drugs

  2008cites this paper
• Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man.

  2008cites this paper
• Neurologic Complications of Liver Transplantation in Pediatric Patients With the Hepatic Form of Wilson's Disease

  2008cites this paper
• Effects of vitamin E supplementation on plasma membrane permeabilization and fluidization induced by chlorpromazine in the rat brain

  2008cites this paper
• High-Dose Ziprasidone Monotherapy in Bipolar I Disorder Patients With Depressed or Mixed Episodes

  2008cites this paper
• Tardive dyskinesia with schizophrenic relapse.

  2008cites this paper
• Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

  2008cites this paper